Fluconazole exposure and selection for Candida non-albicans

Anesthesia and Analgesia

Volumn 107, Issue 6, 2008, Pages 2091-

  Vandijck, Dominique M ^a   Blot, Stijn I ^a,b   Vandekerckhove, Linos ^b   Vogelaers, Dirk P ^a,b,c  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY COLLEGE GHENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; PYRROLE DERIVATIVE; ANTIFUNGAL AGENT;

CANDIDA; CANDIDIASIS; DISEASE TRANSMISSION; DRUG EXPOSURE; DRUG USE; LETTER; PRIORITY JOURNAL; RISK FACTOR; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; NOTE;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; FLUCONAZOLE; HUMANS;

EID: 58149302623     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181896c22     Document Type: Letter

References (5)

1. Dimopoulos G, Ntziora F, Rachiotis G, Armaganidis A, Falagas ME. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg 2008;106:523-9
2. Blot S, Janssens R, Claeys G, Hoste E, Buyle F, De Waele JJ, Peleman R, Vogelaers D, Vandewoude K. Effect of fluconazole consumption on long-term trends in Candidal ecology. J Antimicrob Chemother 2006;58:474 -7
3. Blot S, Vandewoude K, Hoste E, Poelaert J, Colardyn F. Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata. J Hosp Infect 2001;47:308-13
4. Snydman DR. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 2003;123:500S-3S
5. Blot S, Vandewoude K. Management of invasive candidiasis in critically ill patients. Drugs 2004;64:2159-75